27736 Painful retiform purpura with cutaneous necrosis

2021 ◽  
Vol 85 (3) ◽  
pp. AB160
Author(s):  
Alfredo Siller ◽  
Joseph Jebain ◽  
Yomna Amer ◽  
Christopher T. Haley ◽  
Leon Chen ◽  
...  
2020 ◽  
Vol 4 (6) ◽  
pp. 595-598
Author(s):  
Alfredo Siller Jr. ◽  
Joseph Jebain ◽  
Yomna Amer ◽  
Christopher T. Haley ◽  
Leon Chen ◽  
...  

Levamisole-induced vasculitis is characterized by a painful, purpuric rash in a retiform or stellate pattern with or without central necrosis that commonly involves the trunk, extremities, digits, distal nose, cheeks, and ear helices. This clinical syndrome is associated with the use of levamisole-adultered cocaine. Histologic findings for levamisole-induced vasculitis are not disease specific but may include leukocytoclastic vasculitis, microvascular thrombosis, and panniculitis. Laboratory findings of levamisole-induced toxicity include agranulocytosis, neutropenia, hepatotoxicity, glomerulonephritis, pulmonary hemorrhage, and positive p-ANCA, c-ANCA tests, ANA, or lupus anticoagulant. The differential diagnosis for levamisole-induced vasculitis includes leukocytoclastic vasculitis, drug reaction, cryoglobulinemia, idiopathic thrombocytopenic purpura, granulomatosis with polyangiitis, Churg-Strauss syndrome, and polyarteritis nodosa. Levamisole-induced vasculitis typically resolves spontaneously with cessation of cocaine use however; recurrence is common following re-exposure.


2015 ◽  
pp. bcr2015211768 ◽  
Author(s):  
Parinita A Dherange ◽  
Norman Beatty ◽  
Ahmad Al-Khashman

2019 ◽  
Vol 41 (24) ◽  
pp. 2337-2337
Author(s):  
Maks Mihalj ◽  
Miralem Pasic ◽  
Thierry Carrel

2021 ◽  
Vol 9 ◽  
pp. 2050313X2110251
Author(s):  
Michelle Aaron ◽  
Yu Qing Huang ◽  
Danielle Bouffard ◽  
Jean-Pascal Costa ◽  
Benoît Côté

A 66-year-old woman presented to the hospital with cutaneous necrosis of her right ankle and foot. Her symptoms began immediately after an intra-articular injection of hyaluronic acid for ankle osteoarthritis, which was performed 6 days before. Histopathology showed an intra-vascular hyaluronic acid embolus. The initial treatment approach was conservative, but the patient’s clinical state degraded. She was thus treated with sub-cutaneous hyaluronidase, the enzyme that degrades hyaluronic acid, which yielded a moderate improvement even though it was administered 22 days after the initial hyaluronic acid injection. Although hyaluronic acid embolism and subsequent cutaneous necrosis are well-known complications of dermal fillers, there are few reported cases of embolism following intra-articular injection. To our knowledge, this is the first time hyaluronidase has been used in this setting.


1986 ◽  
Vol 15 (2) ◽  
pp. 393-398 ◽  
Author(s):  
Robert J. Korenberg ◽  
Debra Landau-Price ◽  
Neal S. Penneys

Dermatology ◽  
1989 ◽  
Vol 178 (4) ◽  
pp. 194-201 ◽  
Author(s):  
C. Francès ◽  
B. Tribout ◽  
S. Boisnic ◽  
L. Drouet ◽  
A.M. Piette ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document